Epigenomics adjusts conversion price on outstanding mandatory convertible bond after EUR 219,244 capital increase
Epigenomics reset the conversion price on its mandatory convertible bond 2021/2027 following a registered cash capital increase. Adjusted conversion ratio set at 1 (nominal EUR 100): 4.7438 shares, effective Oct. 15, 2026. Company issued 219,244 new registered shares at an issue price of EUR 1.00 per share. Disclaimer